Currently, drugs like L-Dopa, alone or in combination with catechol-O-methyltransferase (COMT) inhibitors/monoamine oxidase B (MAO-B) inhibitors, are used to relieve the symptomatic problems associated with PD. This evidence concerns the gene COMT and Parkinson disease.